Search

everythinglearnresearchcommunity

for

Search:↓

Combining PRP with follicular transplantation improves vitiligo treatment better than follicular transplantation alone.

A woman's hair turned white after taking a cancer drug called dasatinib.

Valproic acid can cause low platelet counts, especially at high doses or in elderly patients.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Adriamycin and ifosfamide together work best for advanced soft tissue sarcomas.

Vorasidenib can cause unusual hair growth.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

Entospletinib effectively prevents eye and skin GVHD in mice.

Butin is effective in treating vitiligo in mice.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Newly made nicotinamide compounds could potentially treat cancer.

Bcl-2 overexpression protects against UVB damage but worsens hair loss from chemotherapy.

Adverse events from vismodegib can be managed effectively to ensure optimal treatment.

Povidone-iodine nail solution effectively treats nail infections caused by chemotherapy.

Valproic acid can cause a skin condition called leukocytoclastic vasculitis, which usually gets better after stopping the drug.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Acute leukemias with the Philadelphia chromosome may be biphenotypic, and identifying this is important for proper treatment.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.

Inducing survivin in normal tissues can protect against radiation damage.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

A woman developed severe bladder inflammation after cancer treatment with Cytoxan.

Two boys developed a viral skin infection during chemotherapy, which resolved with improved immune function.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.